Ultrasound Guided Femoral Nerve Block

Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Mar 5, 2015

Keywords

ClinConnect Summary

This clinical trial is investigating a new way to manage pain for patients with hip fractures. Specifically, it is comparing a technique called Ultrasound Guided Femoral Nerve Block (USFNB) with the usual treatment, which involves giving opioid pain medications through an injection. The goal is to see if the nerve block can provide the same level of pain relief as the standard medication.

To participate in the study, you must be at least 18 years old and have a confirmed hip fracture that causes moderate to severe pain. However, if you have had allergic reactions to local anesthetics, signs of infection near where the needle would be placed, or certain blood-thinning medications, you may not be eligible. If you join the trial, you will receive either the nerve block or the standard pain medication, and medical staff will monitor your pain levels to determine which method works best. This study is currently looking for participants, so it’s an opportunity to help advance pain management for hip fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18 years of age presenting to the ED with radiographically established intra-, extracapsular hip fracture, able to consent and participate in the study and who have moderate to severe pain (numerical pain score \>= 31) at the time of enrollment.
• Exclusion Criteria:
• • Patients with a previous history of hypersensitivity to local anesthetics,
• • Patients who have signs of a local infection at the site of planned needle placement.
• • INR \> 1.4NOAC use within 48 hours
• • Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours
• • Therapeutic LMWH within 24 hours
• • Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours